Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6.
Young Eun LeeGa-Yeon GoEun-Young KohHan-Na YoonMinkoo SeoSeung-Mo HongJi Hye JeongJin-Chul KimDuck ChoTae Sung KimSong Cheol KimEunsung JunMihue JangPublished in: Journal for immunotherapy of cancer (2023)
-CAF-containing pancreatic cancer allows improvements in the therapy of pancreatic ductal adenocarcinoma.